⚖️DEA Revokes Registration of Victor Augusto Silva, M.D.
The Drug Enforcement Administration has revoked the registration of Dr. Victor Augusto Silva due to violations that allowed an unauthorized individual to prescribe controlled substances. This decision underscores the strict compliance required under federal and Florida laws regarding the use of DEA registrations and the serious implications of non-compliance for medical practitioners.
Learn More⚖️DEA Revocation of Registration
The Drug Enforcement Administration (DEA) revoked Ajumobi Agu, M.D.'s registration due to sustained illegal activity, including dispensing controlled substances without appropriate licenses. The order emphasizes the importance of compliance with both federal and state laws in the healthcare field, and the potential consequences for practitioners engaged in similar misconduct.
Learn More📄Correction Notice from the U.S. Department of Justice – April 2025
The U.S. Department of Justice issued a clarification for "Decision and Order" concerning Phong H. Tran, M.D. The notice corrects a publication error in the Federal Register, explicitly specifying a date to replace placeholders in previously published information. This ensures accuracy in regulatory documentation.
Learn More⚖️DEA Revocation Order Impacts Healthcare Business Compliance
The Drug Enforcement Administration (DEA) issued an Order to Show Cause proposing to revoke the registration of Mary Massullo, D.O. due to her lack of authority to handle controlled substances in Ohio, following the permanent revocation of her medical license. The decision emphasizes the importance of compliance with state regulations for medical practitioners and organizations involved in controlled substance handling.
Learn More🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Learn More🍃DEA Notice on Bulk Manufacturing of Controlled Substances
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More⚖️DEA Revocation of Joely Keen's Registration
The Drug Enforcement Administration has revoked Joely Keen's DEA registration after finding that she lacks the necessary state authority to handle controlled substances in Texas. This decision stems from the revocation of her nursing licenses and failure to maintain a prescriptive authority agreement, highlighting the importance of compliance in the healthcare field.
Learn More💊Notice of Application for Bulk Manufacturing by Promega Corporation
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Restek Corporation's Import Application for Controlled Substances Notice
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More🚫DEA Revocation Order for Dr. Thomas Andr'e Endicott, D.D.S.
The Drug Enforcement Administration has revoked the DEA registration of Thomas Andr'e Endicott, D.D.S., due to the revocation of his dental and controlled substance licenses in Utah. This decision highlights the necessity for practitioners to maintain state licensing to uphold their DEA registrations, emphasizing regulatory compliance in the healthcare field.
Learn More